These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36967449)

  • 1. Artificial intelligence reveals dysregulation of osteosarcoma and cuproptosis-related biomarkers, PDHA1, CDKN2A and neutrophils.
    Jiang J; Zhan X; Wei J; Fan Q; Li H; Li H; Li S; Zhao Y; Yin G; Tang L; Wu Y; Lan M; Qin Y; Guo Q; Xu W; Lu L; Yang Y; Zhang Y; Qu H
    Sci Rep; 2023 Mar; 13(1):4927. PubMed ID: 36967449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model.
    Wan H; Yang X; Sang G; Ruan Z; Ling Z; Zhang M; Liu C; Hu X; Guo T; He J; Liu D; Pei J
    Aging (Albany NY); 2023 Oct; 15(20):11244-11267. PubMed ID: 37857018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
    Zhang D; Wang T; Zhou Y; Zhang X
    Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
    Wang X; Chen X; Xu C; Zhou W; Wu D
    Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
    Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
    Mohseny AB; Tieken C; van der Velden PA; Szuhai K; de Andrea C; Hogendoorn PC; Cleton-Jansen AM
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1095-103. PubMed ID: 20737480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating artificial intelligence in osteosarcoma prognosis: the prognostic significance of SERPINE2 and CPT1B biomarkers.
    Qu H; Jiang J; Zhan X; Liang Y; Guo Q; Liu P; Lu L; Yang Y; Xu W; Zhang Y; Lan S; Chen Z; Lu Y; Ou Y; Qin Y
    Sci Rep; 2024 Feb; 14(1):4318. PubMed ID: 38383657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer.
    Cheng X; Yang F; Li Y; Cao Y; Zhang M; Ji J; Bai Y; Li Q; Yu Q; Gao D
    Aging (Albany NY); 2024 Jun; 16(12):10512-10538. PubMed ID: 38888512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
    Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP; Burns KL; Rosenberg AE; Louis DN
    Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients.
    Ni S; Hong J; Li W; Ye M; Li J
    Cancer Med; 2023 Feb; 12(4):5009-5024. PubMed ID: 36129020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15.
    Jiang J; Qu H; Zhan X; Liu D; Liang T; Chen L; Huang S; Sun X; Chen J; Chen T; Li H; Yao Y; Liu C
    Sci Rep; 2023 Mar; 13(1):5255. PubMed ID: 37002245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning.
    Luo H; Yan J; Zhang D; Zhou X
    Front Immunol; 2023; 14():1152223. PubMed ID: 37533853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations.
    Zhang H; Mao JS; Hu WF
    Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma.
    Jiang J; Chu D; Lai X; Liu L; Tao J
    Comput Math Methods Med; 2022; 2022():6314182. PubMed ID: 36388161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress.
    Chang B; Hu Z; Chen L; Jin Z; Yang Y
    Front Immunol; 2023; 14():1090596. PubMed ID: 36817415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.